#mpox

#mpox

Tecovirimat (TPOXX) fails to improve mpox symptoms in trial, adding to global health concerns.

Mpox outbreaks remain severe in Africa, particularly the DRC, despite decreased cases in other regions.

The WHO has authorized a vaccine against mpox for adults, an important breakthrough in the fight against outbreaks in Africa.

Mpox is spreading rapidly in Kinshasa and surrounding areas, posing significant public health risks in overcrowded communities.

California reports first US case of a new mpox outbreak from Clade I, related to infections in Africa.

The first case of the clade I variant of mpox has been detected in the U.S., highlighting an emerging health concern.

WHO approves first rapid mpox diagnostic test to combat rising global cases.

New PCR test enables immediate detection, critical for tackling mpox outbreaks.

Urgent need for testing and vaccination amidst increasing mpox cases in Africa.

Sierra Leone declares a public health emergency due to confirmed mpox cases, initiating urgent health measures.

The Democratic Republic of Congo faces a major mpox outbreak with delayed vaccine deliveries complicating the response to protect children and others at risk.

A 5-year-old boy's mysterious illness led doctors in Congo to consider mpox after ruling out various common diseases, emphasizing challenges in diagnosing rare conditions.

Urgent efforts are underway in DRC to combat the mpox outbreak, especially among children under ten. Treatment is currently symptomatic.

Medical staff in DR Congo urgently need vaccines to control the mpox outbreak as patient numbers, especially among infants, continue to rise.

Treatment protocols for mpox at Munigi Health Center focus on symptom management due to lack of specific treatments, impacting mainly children.

The WHO is set to deliver mpox vaccines to the DRC soon, aiming to control an outbreak exacerbated by political instability.